|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent TMHC insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why TMHC insider buys are important for investors to follow.
Date | Insider | Price | Amount |
3-12-2020 Insider Buy |
Joseph Terracciano Chief Accounting Officer |
$14.15
CAGR »
|
$7,075.00 500 shares |
2-19-2016 Insider Buy |
TPG Group Holdings (SBS) Advisors, Inc. >10% Owner |
$13.18
CAGR »
|
$4,380,588.47 332,332 shares |
2-16-2016 Insider Buy |
TPG Group Holdings (SBS) Advisors, Inc. >10% Owner |
$11.92
CAGR »
|
$6,284,343.87 527,400 shares |
2-9-2016 Insider Buy |
C. David Cone Vice President and CFO |
$11.31
CAGR »
|
$24,888.82 2,200 shares |
2-8-2016 Insider Buy |
Sheryl Palmer President and CEO |
$11.35
CAGR »
|
$85,135.00 7,500 shares |
2-9-2016 Insider Buy |
Joseph Terracciano Chief Accounting Officer |
$11.75
CAGR »
|
$599.42 51 shares |
2-8-2016 Insider Buy |
Anne L. Mariucci Director |
$11.28
CAGR »
|
$100,632.05 8,925 shares |
2-10-2016 Insider Buy |
TPG Group Holdings (SBS) Advisors, Inc. >10% Owner |
$11.58
CAGR »
|
$7,412,885.00 640,000 shares |
8-8-2014 Insider Buy |
C. David Cone Vice President and CFO |
$17.91
CAGR »
|
$100,296.00 5,600 shares |
8-19-2013 Insider Buy |
Tawn Kelley President TMHF, Manager MFDV |
$20.50
CAGR »
|
$25,010.00 1,220 shares |
8-16-2013 Insider Buy |
Sheryl Palmer President and CEO |
$20.50
CAGR »
|
$102,500.00 5,000 shares |
5-17-2013 Insider Buy |
Sheryl Palmer President and CEO |
$25.57
CAGR »
|
$51,140.00 2,000 shares |
4-29-2013 Insider Buy |
Tawn Kelley President, TMHF and MFDV |
$26.18
CAGR »
|
$54,980.00 2,100 shares |
Also See: Institutional Holders of TMHC
Also See: SEC filings
Below we present the annualized performance delivered by TMHC stock since 3-12-2020 (the date of the most recent
insider purchase). The performance of the investment from the time TMHC insider buying occurred is the ultimate
test of whether insiders were right about TMHC being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/13/2020 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$14.52 |
|
End price/share: |
$56.35 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
288.09% |
|
Average Annual Total Return: |
39.00% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$38,806.77 |
|
Years: |
4.12 |
|
TMHC Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent TMHC insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding TMHC
|
|